Calquence significantly prolonged time patients lived without disease progression or death in previously untreated CLL
The Independent Review Committee (IRC)-assessed results were presented at the 2019 American Society of Hematology Annual Meeting and Exhibition in Orlando, US. At a median follow-up of 28.3